Home

Patetico divorzio Indomabile bria oncologia gemelli interruttore cranio il primo

Final results of the SENECA (SEcond line NintEdanib in non-small cell lung  CAncer) trial - Lung Cancer
Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial - Lung Cancer

Management of locally advanced non-small cell lung cancer in the modern  era: A national Italian survey on diagnosis, treatment and  multidisciplinary approach | PLOS ONE
Management of locally advanced non-small cell lung cancer in the modern era: A national Italian survey on diagnosis, treatment and multidisciplinary approach | PLOS ONE

Sopravvivenza avanzata e globale - Bria - YouTube
Sopravvivenza avanzata e globale - Bria - YouTube

PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in  Patients With EGFR-mutant Advanced Non–small-cell Lung Cancer Receiving  Tyrosine Kinase Inhibitors - Clinical Lung Cancer
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non–small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors - Clinical Lung Cancer

BRIA EMILIO - Docente Università Cattolica del Sacro Cuore
BRIA EMILIO - Docente Università Cattolica del Sacro Cuore

Tomography | Free Full-Text | Cryoablation in Locoregional Management of  Complex Unresectable Chest Neoplasms
Tomography | Free Full-Text | Cryoablation in Locoregional Management of Complex Unresectable Chest Neoplasms

The lung immuno-oncology prognostic score (LIPS-3): a prognostic  classification of patients receiving first-line pembrolizumab for PD-L1 ≥  50% advanced non-small-cell lung cancer - ESMO Open
The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer - ESMO Open

Frontiers | Primary versus secondary antiemetic prophylaxis with NK1  receptor antagonists in patients affected by gastrointestinal malignancies  and treated with a doublet or triplet combination regimen including  oxaliplatin and/or irinotecan plus ...
Frontiers | Primary versus secondary antiemetic prophylaxis with NK1 receptor antagonists in patients affected by gastrointestinal malignancies and treated with a doublet or triplet combination regimen including oxaliplatin and/or irinotecan plus ...

Management of locally advanced non-small cell lung cancer in the modern  era: A national Italian survey on diagnosis, treatment and  multidisciplinary approach | PLOS ONE
Management of locally advanced non-small cell lung cancer in the modern era: A national Italian survey on diagnosis, treatment and multidisciplinary approach | PLOS ONE

A due giovani ricercatrici di Università Cattolica e Fondazione Policlinico  Gemelli il "Merit Award" di ASCO - Policlinico Universitario A. Gemelli  IRCCS
A due giovani ricercatrici di Università Cattolica e Fondazione Policlinico Gemelli il "Merit Award" di ASCO - Policlinico Universitario A. Gemelli IRCCS

The Immunotherapy (I-O) Perspective [Metastatic Setting]
The Immunotherapy (I-O) Perspective [Metastatic Setting]

Tumore del polmone non a piccole cellule, pembrolizumab efficace a
Tumore del polmone non a piccole cellule, pembrolizumab efficace a

High familial burden of cancer correlates with improved outcome from  immunotherapy in patients with NSCLC independent of somatic DNA damage  response gene status | Journal of Hematology & Oncology | Full Text
High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status | Journal of Hematology & Oncology | Full Text

AIOM abstracts, 2021
AIOM abstracts, 2021

A Definitive Prognostication System for Patients With Thoracic Malignancies  Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT  Registry - Journal of Thoracic Oncology
A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry - Journal of Thoracic Oncology

Trattamento dei pazienti con ES-SCLC e immunoterapia, le questioni sul  tavolo - OncoInfo
Trattamento dei pazienti con ES-SCLC e immunoterapia, le questioni sul tavolo - OncoInfo

Nuovo assetto organizzativo per l'area clinico – assistenziale e di ricerca  di Gemelli Molise – Gemelli Molise
Nuovo assetto organizzativo per l'area clinico – assistenziale e di ricerca di Gemelli Molise – Gemelli Molise

Frontiers | The Therapeutic Challenge of Disseminated Bone Marrow  Metastasis From HR-Positive HER2-Negative Breast Cancer: Case Report and  Review of the Literature
Frontiers | The Therapeutic Challenge of Disseminated Bone Marrow Metastasis From HR-Positive HER2-Negative Breast Cancer: Case Report and Review of the Literature

Targeted next-generation sequencing identifies genomic abnormalities  potentially driving the prognosis of early-stage invasive lobular breast  carcinoma patients stratified according to a validated clinico-pathological  model - The Breast
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model - The Breast

Gemelli Molise
Gemelli Molise

Neoadjuvant treatment: A window of opportunity for nutritional  prehabilitation in patients with pancreatic ductal adenocarcinoma
Neoadjuvant treatment: A window of opportunity for nutritional prehabilitation in patients with pancreatic ductal adenocarcinoma

Il Gemelli nel segno dell'integrazione: circuito virtuoso da Roma al Molise  | PrimoPiano Molise
Il Gemelli nel segno dell'integrazione: circuito virtuoso da Roma al Molise | PrimoPiano Molise

La prevenzione del tumore ai polmoni nel settimo appuntamento di "Insieme  in salute" | Il Colibrì
La prevenzione del tumore ai polmoni nel settimo appuntamento di "Insieme in salute" | Il Colibrì

A Proposito di Salute - Oncologia: quali sono le novità nella ricerca  oncologica - RTL 102.5 Play
A Proposito di Salute - Oncologia: quali sono le novità nella ricerca oncologica - RTL 102.5 Play

Il legame fra composizione del microbiota ed efficacia dei farmaci  oncologici - YouTube
Il legame fra composizione del microbiota ed efficacia dei farmaci oncologici - YouTube

Salute Domani - Il corpo ci parla, impariamo ad ascoltarlo. Progetto  servizio di psicologia del Policlinico Gemelli
Salute Domani - Il corpo ci parla, impariamo ad ascoltarlo. Progetto servizio di psicologia del Policlinico Gemelli

Predictive ability of a drug-based score in patients with advanced  non–small-cell lung cancer receiving first-line immunotherapy - European  Journal of Cancer
Predictive ability of a drug-based score in patients with advanced non–small-cell lung cancer receiving first-line immunotherapy - European Journal of Cancer